ONK Therapeutics operates internationally with its primary research and development laboratories and corporate global headquarters situated in Galway, Ireland. The company also maintains significant operational networks and collaborative ties to support its work in natural killer cell therapies. This strategic location places its primary operational hubs within a thriving European biotechnology and medical research ecosystem, allowing the firm to coordinate closely with international clinical trial investigators and academic medical centers.